![Beth Psaila: Thrilled to receive a Senior Science and Innovation at Cancer Research UK Fellowship](https://oncodaily.com/pub/uploads/2024/08/download-94-1280x721.png)
Beth Psaila: Thrilled to receive a Senior Science and Innovation at Cancer Research UK Fellowship
Beth Psaila shared a post on X by Science and Innovation at Cancer Research UK adding:
“Totally thrilled to receive a Senior Science and Innovation at Cancer Research UK Fellowship. Extremely grateful to work with an amazing team and brilliant colleagues MRC WIMM, University of Oxford and excited about what this funding will enable us to achieve over the next 6years!”
Quoting Science and Innovation at Cancer Research UK’s post below:
“Bethan Psaila received a Senior Cancer Research Fellowship from our Research Careers Committee, jointly funded with Rosetrees Trust, to examine the development and impact of malignant bone marrow niches on Blood Cancer evolution to inspire disease-modifying therapies.”
Sources: Beth Psaila/X and Quoting Science and Innovation at Cancer Research UK/X
Beth Psaila is a Co-Founder of Alethiomics and an Associate Professor of Haematology at the University of Oxford. She is also a Senior Fellow at New College, Oxford, and a Cancer Research UK Advanced Clinician Scientist at the MRC Weatherall Institute of Molecular Medicine. Her research focuses on the biology of normal and malignant megakaryocytes and platelets, with a clinical interest in myeloproliferative neoplasms.